New NuvaRing Helpline LaunchedNuvaRing Helpline Lauched by Yazbirthcontrolpillshelpline.com NuvaRing lawyers of yazbirthcontrolpillshelpline.com are Reviewing cases for Blood Clots for the NuvaRing Birth Control Device. Yaz and Yasmin have similiar lawsuits pending.
By: attorney referrals service July 8, 2012 - PRLog -- NuvaRing Helpline Lauched by Yazbirthcontrolpillshelpline.com
NuvaRing lawyers of yazbirthcontrolpillshelpline.com are Reviewing cases for Blood Clots for the NuvaRing Birth Control Device. Yaz and Yasmin have similiar lawsuits pending. "Just like with our Yaz callers we are hearing Blood clots, Pulmonary embolism, stroke and in some severe cases deaths". The NuvaRing birth control device was first approved by the FDA in 2001. In October 2011, the FDA released a drug safety study report indicating the NuvaRing was associated with a significantly higher risk of developing deep vein thrombosis (blood clots in the legs) and pulmonary embolism (blood clots in the lungs) than standard low-dose estrogen birth control pills. Now, according to new results published this month in the British Medical Journal, women using the vaginal ring are at a significantly higher risk for venous thrombosis (blood clots) compared to those taking earlier generation oral contraceptive birth control. call 1 877 522-2123 see yazbirthcontrolpillshelpline.com All hormonal contraceptions come with some risk of blood clots, which can lead to other complications like deep vein thrombosis and even life-threatening pulmonary embolism and stroke. Danish researchers, however, studied pregnant women ages 15-49 who were free of any prior thrombotic disease, between 2001 and 2010, and discovered that women who use vaginal rings like the NuvaRing for contraception have a 6.5 times increased risk of confirmed venous thrombosis compared with non-users of hormonal contraception. The researchers further noted that “the vaginal ring conferred a 90% higher risk of venous thrombosis than did combined oral contraceptives containing levonorgestrel, bringing the risk to the same level as that of combined oral contraceptives with third and fourth generation progestogens”— This NuvaRing study brings new information critical to women evaluating the use of their contraception NuvaRing Lawyers reviewing cases for NuvaRing. According to a New Study in the British Medical Journal NuvaRing May Double the Risk for Serious Blood Clots, including Deep Vein Thrombosis and Pulmonary Embolism, Compared to Birth Control Pills Melville, NY (PRWEB) May 14, 2012 According to a New Study in the British Medical Journal NuvaRing May Double the Risk for Serious Blood Clots, including Deep Vein Thrombosis and Pulmonary Embolism, "We have seen an increase in calls for NuvaRing Bloodclots and deaths". Says the helpline representative." End
Account Email Address Account Phone Number Disclaimer Report Abuse
|